Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity - PubMed (original) (raw)

Comparative Study

doi: 10.1007/s12253-011-9369-8. Epub 2011 Apr 1.

Affiliations

• PMID: 21455637
• DOI: 10.1007/s12253-011-9369-8

Free article

Comparative Study

Expression of tankyrase 1 in gastric cancer and its correlation with telomerase activity

Jinbo Gao et al. Pathol Oncol Res. 2011 Sep.

Free article

Abstract

Tankyrase 1, which enhances telomerase access to telomeres, plays an important role in telomere maintenance. The aim of this study was to determine the expression and potential role of tankyrase 1 in gastric cancer development and progression. We examined the expression of tankyrase 1 by RT-PCR and Western blotting, and assessed telomerase activity by TRAP-ELISA method in gastric cancer and adjacent normal tissues. We found that tankyrase 1 expression was significantly up-regulated in gastric cancer tissues compared to normal corresponding tissues. Tankyrase 1 over-expression by gastric cancerous tissue was significantly associated with tumor histology differentiation and tumor stage. Moreover, tankyrase 1 expression was significantly correlation with telomerase activity. Our results indicate that tankyrase 1 over-expression may play an important role in gastric cancer development and progression. Tankyrase 1 may be used as a biomarker of gastric cancer and may serve as a target for cancer therapy.

PubMed Disclaimer

Similar articles

• Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors.
  Zhang H, Yang MH, Zhao JJ, Chen L, Yu ST, Tang XD, Fang DC, Yang SM. Zhang H, et al. Oncol Rep. 2010 Oct;24(4):1059-65. doi: 10.3892/or.2010.1059. Oncol Rep. 2010. PMID: 20811689
• Expression of telomeric repeat binding factor 1 and 2 and TRF1-interacting nuclear protein 2 in human gastric carcinomas.
  Matsutani N, Yokozaki H, Tahara E, Tahara H, Kuniyasu H, Haruma K, Chayama K, Yasui W, Tahara E. Matsutani N, et al. Int J Oncol. 2001 Sep;19(3):507-12. Int J Oncol. 2001. PMID: 11494028
• The telomeric PARP, tankyrases, as targets for cancer therapy.
  Seimiya H. Seimiya H. Br J Cancer. 2006 Feb 13;94(3):341-5. doi: 10.1038/sj.bjc.6602951. Br J Cancer. 2006. PMID: 16421589 Free PMC article. Review.
• Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia.
  Miglani M, Pasha Q, Gupta A, Priyadarshini A, Pati Pandey R, Vibhuti A. Miglani M, et al. Drug Discov Today. 2021 Nov;26(11):2774-2781. doi: 10.1016/j.drudis.2021.07.012. Epub 2021 Jul 22. Drug Discov Today. 2021. PMID: 34302973 Review.

Cited by

• Cross-talk of Three Molecular Subtypes of Telomere Maintenance Defines Clinical Characteristics and Tumor Microenvironment in Gastric Cancer.
  Yan M, Zhang Z, Wang L, Huang H, Wang J, Zhu C, Li Z, Xu Z. Yan M, et al. J Cancer. 2024 Apr 15;15(10):3227-3241. doi: 10.7150/jca.92207. eCollection 2024. J Cancer. 2024. PMID: 38706908 Free PMC article.
• Knockdown of tankyrase 1 inhibits the progression of gastric adenocarcinoma via regulating human telomerase reverse transcriptase and telomeric repeat binding factor 1.
  Liu W, Zhu JJ, Liu YY, Tang NN, Wang Y, Jiang B, Wang LL, Wang YX, Xie MP, Wang XY. Liu W, et al. J Gastrointest Oncol. 2022 Apr;13(2):559-568. doi: 10.21037/jgo-22-82. J Gastrointest Oncol. 2022. PMID: 35557584 Free PMC article.
• Intracellular distribution of Tankyrases as detected by multicolor immunofluorescence techniques.
  Bottone MG, Santin G, Soldani C, Veneroni P, Scovassi AI, Alpini C. Bottone MG, et al. Eur J Histochem. 2012 Jan 20;56(1):e4. doi: 10.4081/ejh.2012.e4. Eur J Histochem. 2012. PMID: 22472892 Free PMC article.
• Analysis of Genes Involved in Body Weight Regulation by Targeted Re-Sequencing.
  Volckmar AL, Han CT, Pütter C, Haas S, Vogel CI, Knoll N, Struve C, Göbel M, Haas K, Herrfurth N, Jarick I, Grallert H, Schürmann A, Al-Hasani H, Hebebrand J, Sauer S, Hinney A. Volckmar AL, et al. PLoS One. 2016 Feb 1;11(2):e0147904. doi: 10.1371/journal.pone.0147904. eCollection 2016. PLoS One. 2016. PMID: 26828654 Free PMC article.

References

1. 1. Clin Chem Lab Med. 2007;45(7):862-6 - PubMed
2. 1. Mod Pathol. 2003 Jul;16(7):700-7 - PubMed
3. 1. Curr Biol. 2000 Oct 19;10(20):1299-302 - PubMed
4. 1. Biochem J. 2007 Mar 1;402(2):279-90 - PubMed
5. 1. Science. 1994 Dec 23;266(5193):2011-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Hungarian Oncological Association
  • Springer

• Medical

  • MedlinePlus Health Information